Quantitation of hematoporphyrin derivative in human gliomas, experimental central nervous system tumors, and normal tissues.
D000818:Animals; D001254:Astrocytoma / Q000032:analysis; D001932:Brain Neoplasms / Q000032:analysis* / Q000628:therapy; D005910:Glioma / Q000032:analysis* / Q000628:therapy; D017324:Hematoporphyrin Derivative; D006415:Hematoporphyrins / Q000032:analysis* / Q000627:therapeutic use; D006801:Humans; D007263:Infusions, Parenteral; D008856:Microscopy, Fluorescence; D009374:Neoplasms, Experimental / Q000032:analysis; D009837:Oligodendroglioma / Q000032:analysis; D011838:Radiation-Sensitizing Agents / Q000032:analysis* / Q000627:therapeutic use; D011879:Radiotherapy Dosage; D051381:Rats; D011919:Rats, Inbred Strains
D006415:Hematoporphyrins; D011838:Radiation-Sensitizing Agents; D017324:Hematoporphyrin Derivative